gefitinib has been researched along with gossypol acetic acid in 1 studies
| Studies (gefitinib) | Trials (gefitinib) | Recent Studies (post-2010) (gefitinib) | Studies (gossypol acetic acid) | Trials (gossypol acetic acid) | Recent Studies (post-2010) (gossypol acetic acid) |
|---|---|---|---|---|---|
| 5,231 | 566 | 2,919 | 209 | 16 | 77 |
| Protein | Taxonomy | gefitinib (IC50) | gossypol acetic acid (IC50) |
|---|---|---|---|
| Mcl-1 | Homo sapiens (human) | 1.2628 | |
| Valosin-containing protein | Homo sapiens (human) | 5.386 | |
| Muscarinic acetylcholine receptor M1 | Rattus norvegicus (Norway rat) | 1.17 | |
| Muscarinic acetylcholine receptor M3 | Rattus norvegicus (Norway rat) | 1.17 | |
| Muscarinic acetylcholine receptor M4 | Rattus norvegicus (Norway rat) | 1.17 | |
| Muscarinic acetylcholine receptor M5 | Rattus norvegicus (Norway rat) | 1.17 | |
| 60 kDa heat shock protein, mitochondrial | Homo sapiens (human) | 1.2 | |
| Muscarinic acetylcholine receptor M2 | Rattus norvegicus (Norway rat) | 1.17 | |
| 10 kDa heat shock protein, mitochondrial | Homo sapiens (human) | 1.2 | |
| 60 kDa chaperonin | Escherichia coli | 0.545 | |
| 10 kDa chaperonin | Escherichia coli | 0.545 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hai, P; Wang, YY; Xia, B; Zhang, CY; Zhao, R; Zhe, H; Zhou, S | 1 |
1 other study(ies) available for gefitinib and gossypol acetic acid
| Article | Year |
|---|---|
AT-101 enhances gefitinib sensitivity in non-small cell lung cancer with EGFR T790M mutations.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; bcl-X Protein; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Synergism; ErbB Receptors; Female; Gefitinib; Gossypol; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Myeloid Cell Leukemia Sequence 1 Protein; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-bcl-2; Quinazolines | 2016 |